Patents by Inventor Yves Pouliot

Yves Pouliot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7763257
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-?1, TGF-?2, and dairy derived proteins comprising a large proportion of ?-lactoglobulin.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: July 27, 2010
    Inventors: Christina Juneau, Réjean Drouin, Yves Pouliot, Najat Aattouri, Sylvie Gauthier, Eric Lamiot
  • Publication number: 20100121037
    Abstract: The invention relates to the general field of protein fractionation, and more particularly to the selective fractionation of growth factor from dairy products, such as milk, whey and colostrum. There is provided methods for the selective fractionation of TGF-?, lactoferrin and bovine serum albumin.
    Type: Application
    Filed: April 1, 2008
    Publication date: May 13, 2010
    Applicant: UNIVERSITE LAVAL
    Inventors: David Lachkar, Yves Pouliot, Sylvie Gauthier, Sylvie Turgeon, Eric Lamiot, Christina Juneau
  • Publication number: 20090074893
    Abstract: The invention provides a method for the prevention or treatment of virus infections comprising administering, to a human or animal individual susceptible to or suffering from a virus infection, an effective amount of one or more casein phosphopeptides (CPP). Also provided is a composition containing such casein peptides and further agents such as vitamin C and/or nutritional components for use in treating or preventing virus infections.
    Type: Application
    Filed: April 28, 2006
    Publication date: March 19, 2009
    Applicant: CAMPINA NEDERLAND HOLDING B.V.
    Inventors: Rick de Waard, Yves Pouliot, Christina Juneau, Leon Franciscus Mallee
  • Publication number: 20080031969
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-?1, TGF-?2, and dairy derived proteins comprising a large proportion of ?-lactoglobulin.
    Type: Application
    Filed: April 3, 2007
    Publication date: February 7, 2008
    Inventors: Christina Juneau, Rejean Drouin, Yves Pouliot, Najat Aattouri, Sylvie Gauthier, Eric Lamiot
  • Publication number: 20060127493
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and related disorders. The composition may be comprised of TGF-?l, TGF-?2, and a large proportion of dairy derived proteins.
    Type: Application
    Filed: December 9, 2004
    Publication date: June 15, 2006
    Inventors: Yves Pouliot, Sylvie Gauthier, Eric Lamiot, Najat Aattouri, Christina Juneau
  • Patent number: 6998259
    Abstract: Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. The highest ACE-inhibitory activity was obtained with the purified peptide ?-1g (f142–148) obtained by chemical synthesis, for which an IC50 value of 0.04 mg powder.ml?1 was found. The hydrolysates derived from BiPRO™ whey protein isolate and ?-1g both gave higher antihypertensive activities (IC50 values of 0.29 to 0.90 mg powder.ml?1) than the other hydrolysates tested (IC50 values of 0.96 and 1.30 mg powder.ml?1). The recovered hydrolysate can be used to treat hypertension in mammals such as humans and domestic pets such as dogs and cats.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: February 14, 2006
    Assignee: Davisco Foods International
    Inventors: Martin E. Davis, Anand Rao, Sylvie Gauthier, Yves Pouliot, Line Gourley, Anne-Francoise Allain
  • Publication number: 20050003999
    Abstract: Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. ACE-inhibitory activity and antihypertension activity were obtained with a hydrolysate of whey protein isolate prepared with a porcine trypsin.
    Type: Application
    Filed: November 8, 2002
    Publication date: January 6, 2005
    Inventors: Martin Davis, Anand Rao, Sylvie Gauthier, Yves Pouliot, Line Gourley, Anne-Francoise Allain
  • Patent number: 6630320
    Abstract: Enzymatic digests of whey protein isolates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. The antihypertension activity was obtained with a hydrolysate of whey protein isolate prepared with a porcine trypsin. The recovered hydrolysate is used to treat hypertension in mammals such as humans and domestic pets such as dogs and cats.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: October 7, 2003
    Assignee: Devisco Foods International, Inc.
    Inventors: Martin E. Davis, Anand Rao, Sylvie Gauthier, Yves Pouliot
  • Publication number: 20030171256
    Abstract: Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. ACE-inhibitory activity and antihypertension activity were obtained with a hydrolysate of whey protein isolate prepared with a porcine trypsin.
    Type: Application
    Filed: November 8, 2002
    Publication date: September 11, 2003
    Inventors: Martin E. Davis, Anand Rao, Sylvie Gauthier, Yves Pouliot, Line Gourley, Anne-Francoise Allain